Pausch Jonas, Weimann Jessica, Silaschi Miriam, Alaj Eissa, Seidiramool Vahid, Kofler Markus, Kempfert Jörg, Treede Hendrik, Ghazy Ahmed, Noack Thilo, Gadelkarim Ibrahim, Bleiziffer Sabine, Götte Julia, Reichenspurner Hermann, Conradi Lenard
Department of Cardiovascular Surgery, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Department of Cardiology, University Heart and Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany.
Eur J Cardiothorac Surg. 2025 Jul 1;67(7). doi: 10.1093/ejcts/ezaf219.
To avoid potential groin incision associated complications and further streamline surgery percutaneous femoral cannulation using different vascular closure devices (VCDs) has emerged to establish cardiopulmonary bypass during minimally invasive heart valve surgery (HVS).
The Percutaneous peRipheral cannulatiOn for Minimally InvaSive heart valve surgEry (PROMISE) multicentre registry included patients, receiving percutaneous vascular access site (VAS) closure during minimally invasive HVS. Retrospective analyses were performed to evaluate major and minor VAS-related complications of plug- (group 1) vs suture-based (group 2) systems according to modified Valve Academic Research Consortium (VARC) 3 criteria (ie, retrograde dissection, vascular injury, conversion to surgical cut-down, or vascular intervention).
In total, 755 patients (66.1% (499/755) male; median age 61.9 years) were included and treated using a plug- (n = 450) or suture-based (n = 305) VCD. Most prevalent comorbidities were hypertension (53.8%; 335/755) and atrial fibrillation (29.4%; 222/755), resulting in a median STS Prom Score of 0.5%. Prevalence of peripheral artery disease was 4.4% (33/450). Immediate hemostasis was significantly higher in the plug-based group (99.8% (445/450) vs 77.7% (237/305); P < .001). Accordingly, application of a second VCD (0.0% (0/450) vs 34.8% (106/305); P < .001) as well as conversion rates to surgical cut-down (1.3% (6/450) vs 3.9% (12/305); P = .04) were significantly lower. Prevalence of VAS-related complications (ie, arterio-venous (AV) fistula (0.2% (1/450) vs 0% (0/305); P > .99), pseudoaneurysm (0.4% (2/450) vs 0% (0/305); P = .66), or postoperative VAS bleeding (1.6% (7/450) vs 0.7% (2/305); P = .26)) was low in both the groups (2.9% (13/450) vs 5.2% (16/305); P = .14).
VAS-related complications were favourably low in both the groups. Plug-based VCDs are potentially associated with significantly higher rates of immediate hemostasis and lower incidence for additional VCD or surgical cut-down. Usage of dedicated VCD (plug- and suture-based) for VAS closure after percutaneous cannulation is feasible, safe, and further decreases invasiveness in minimally invasive HVS.
为避免潜在的腹股沟切口相关并发症,并进一步简化手术,在微创心脏瓣膜手术(HVS)期间,使用不同的血管闭合装置(VCD)进行经皮股动脉插管以建立体外循环已应运而生。
微创心脏瓣膜手术经皮外周插管(PROMISE)多中心注册研究纳入了在微创HVS期间接受经皮血管穿刺部位(VAS)闭合的患者。根据改良的瓣膜学术研究联盟(VARC)3标准(即逆行夹层、血管损伤、转为手术切开或血管介入),对基于封堵器(第1组)与基于缝合器(第2组)系统的主要和次要VAS相关并发症进行回顾性分析。
总共纳入755例患者(男性占66.1%(499/755);中位年龄61.9岁),并使用基于封堵器(n = 450)或基于缝合器(n = 305)的VCD进行治疗。最常见的合并症是高血压(53.8%;335/755)和心房颤动(29.4%;222/755),导致中位胸外科医师协会(STS)预估评分0.5%。外周动脉疾病的患病率为4.4%(33/450)。基于封堵器的组即时止血率显著更高(99.8%(445/450)对77.7%(237/305);P <.001)。因此,使用第二个VCD的比例(0.0%(0/450)对34.8%(106/305);P <.001)以及转为手术切开的比例(1.3%(6/450)对3.9%(12/305);P =.04)显著更低。两组VAS相关并发症(即动静脉(AV)瘘(0.2%(1/450)对0%(0/305);P >.99)、假性动脉瘤(0.4%(2/450)对0%(0/305);P =.66)或术后VAS出血(1.6%(7/450)对0.7%(2/305);P =.26))的患病率均较低(2.9%(13/450)对5.2%(16/305);P =.14)。
两组中VAS相关并发症均较低。基于封堵器的VCD可能与显著更高的即时止血率以及更低的额外VCD使用或手术切开发生率相关。经皮插管后使用专用VCD(基于封堵器和基于缝合器)进行VAS闭合是可行、安全的,并且进一步降低了微创HVS的侵入性。